WD

West Deutsche Landesbank Girozentrale

Europe, Nordrhein-Westfalen, Germany, Düsseldorf

Description

German bank WestLB offers a range of banking products and services.

Investor Profile

West Deutsche Landesbank Girozentrale has made 5 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (60%)
  • Series C (20%)
  • Series A (20%)

Country Focus

  • United Kingdom (60%)
  • Germany (20%)
  • United States (20%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Electronics
  • Information Services
  • News
  • Optical Communication
  • Semiconductor
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does West Deutsche Landesbank Girozentrale frequently co-invest with?

ABN AMRO Fund
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Scottish Equity Partners
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 1
Avalon Ventures
North America, California, United States, La Jolla
Co-Investments: 1
Excalibur Fund Managers
Europe, England, United Kingdom, London
Co-Investments: 2
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
PV
Europe, England, United Kingdom, London
Co-Investments: 1
TM
Europe, England, United Kingdom, London
Co-Investments: 3
CLSA
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
GeneChem
Asia, Taejon-jikhalsi, South Korea, Daejeon
Co-Investments: 1
LDC
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by West Deutsche Landesbank Girozentrale?

BioVex

Oxton, York, United Kingdom

BioVex is a biotechnology company developing and commercializing biological treatments for cancer and infectious diseases.

BiotechnologyHealth CareMedical
Series COct 6, 2003
Amount Raised: $28,382,767
BioVex

Oxton, York, United Kingdom

BioVex is a biotechnology company developing and commercializing biological treatments for cancer and infectious diseases.

BiotechnologyHealth CareMedical
Series BJul 30, 2001
Amount Raised: $14,263,056
EndPoints

Bedford, Massachusetts, United States

EndPoints is a fabless semiconductor company.

ElectronicsInformation ServicesNewsOptical CommunicationPharmaceuticalSemiconductor
Series BJan 23, 2001
Amount Raised: $7,000,000
TME Pharma

Berlin, Berlin, Germany

TME Pharma develops biostable aptamers and substances based on mirror image nucleic acids.

BiotechnologyHealth CarePharmaceutical
Series BNov 15, 2000
Amount Raised: $17,155,631
BioVex

Oxton, York, United Kingdom

BioVex is a biotechnology company developing and commercializing biological treatments for cancer and infectious diseases.

BiotechnologyHealth CareMedical
Series AFeb 1, 1999
Amount Raised: $4,925,170